Biogen Issued CRL (complete response letter) for Subcutaneous Natalizumab in Relapsing MS
Just weeks after receiving an EU marketing authorization, the FDA has issued a complete response letter to Biogen for its…
Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis
Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian…
Stuart Schlossman
Natalizumab Improves Social and Mental Health in Patients with Multiple Sclerosis
April 24, 2021 – Victoria Johnson Conferences | American Academy of Neurology Annual Meeting Researchers compared Neuro-QoL scores between patients treated with…
Stuart Schlossman
The Rarity of Adverse Events With Natalizumab Infusion for MS
April 8, 2021 Victoria Johnson NeurologyLive, Advances in Multiple Sclerosis, Yujie Wang, MD, a neurologist from the University of Washington Medical…
Stuart Schlossman
Tysabri Affects Immune System Beyond Known MS Target, Study Finds
NOVEMBER 24, 2020 — BY STEVE BRYSON PHD – MS News Today Click HERE to Subscribe for the MS Beacon…
Stuart Schlossman
Natalizumab (Tysabri) Provides Superior ‘Feel Good’ Experience in MS Over Other Treatments
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ COVID-19 is unprecedented and rapidly changing situation. Get public health information from CDC: https://www.coronavirus.gov Stay Healthy, Stay Home and Wash…
Stuart Schlossman
Long-term Safety and Effectiveness of Natalizumab Treatment in Clinical Practice: 10 Years of Real-World Data From the Tysabri Observational Program (TOP)
2020 Mar 31 Helmut Butzkueven 1, Ludwig Kappos 2, Heinz Wiendl 3, Maria Trojano 4, Tim Spelman 5 6, Ih Chang 7, Rachna Kasliwal 8, Seema Jaitly 8, Nolan Campbell 9, Pei-Ran Ho 9, Stephanie Licata 10, Tysabri Observational Program (TOP) Investigators Collaborators,…
Stuart Schlossman
What to Know About MS and the JC Virus
This common virus is harmless to most of the population. But it can have serious effects for those with multiple…
Stuart Schlossman
#ECTRIMS2019 – Tysabri During Pregnancy and After Delivery Seems Safe, Reduces Relapse Risk, Study Finds
Click here to subscribe to the MS Beacon e-Newsletter by MS Views and News Continuing Tysabri (natalizumab) treatment up to week 28…
Stuart Schlossman
Multiple Sclerosis Vlog: Decoding the JC Virus Antibody Test
Aaron Boster MD Published on Jun 2, 2019 In this video I teach you how to understand the JC virus…
Stuart Schlossman
